Clinical Trial Update: Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating proton beam radiotherapy followed by atezolizumab (Tecentriq) and bevacizumab (Avastin) for hepatocellular carcinoma with portal vein i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Portal Vein Thrombosis

Drugs mentioned

• Avastin (bevacizumab)
• Proton beam radiotherapy
• Tecentriq (atezolizumab)

Snippet

Sponsor: Samsung Medical Center | Conditions: Hepatocellular Carcinoma, Portal Vein Thrombosis | Phase 2 | Status: COMPLETED